C

Castle Biosciences
D

CSTL

23.020
USD
-1.15
(-4.76%)
Market Closed
Volume
44,717
EPS
0
Div Yield
0
P/E
-263
Market Cap
861,503,766
OverviewSignalsIdeasNews
Related Instruments
    ACN
    -2.48
    (-0.75%)
    328.07 USD
    CSCO
    -1.050
    (-2.17%)
    47.380 USD
    C
    CTSH
    0.690
    (0.91%)
    76.330 USD
    INFY
    0.175
    (0.79%)
    22.295 USD
    T
    TCS
    -0.04880
    (-5.51%)
    0.83650 USD
    W
    WIT
    -0.05500
    (-0.89%)
    6.10000 USD
News

Title: Castle Biosciences

Sector: Healthcare
Industry: Diagnostics & Research
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.